Published in Arch Gen Psychiatry on January 01, 1998
Treatment of bipolar disorder. Lancet (2013) 2.93
How patient cost-sharing trends affect adherence and outcomes: a literature review. P T (2012) 1.37
Feasibility and Acceptability of a Mobile Intervention to Improve Treatment Adherence in Bipolar Disorder: A Pilot Study. Behav Modif (2014) 1.06
The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst Abuse Treat Prev Policy (2007) 1.03
Progression of amygdala volumetric abnormalities in adolescents after their first manic episode. J Am Acad Child Adolesc Psychiatry (2011) 0.96
Improving treatment adherence in bipolar disorder: a review of current psychosocial treatment efficacy and recommendations for future treatment development. Behav Modif (2008) 0.94
Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder. Bipolar Disord (2012) 0.93
Reduced subjective response to acute ethanol administration among young men with a broad bipolar phenotype. Neuropsychopharmacology (2012) 0.93
Positive Mood Induction and Facial Affect Recognition among Students at Risk for Mania. Cognit Ther Res (2008) 0.90
Improving treatment adherence in patients with bipolar disorder and substance abuse: rationale and initial development of a novel psychosocial approach. J Psychiatr Pract (2011) 0.86
Adjunctive psychosocial intervention following Hospital discharge for Patients with bipolar disorder and comorbid substance use: A pilot randomized controlled trial. Psychiatry Res (2015) 0.84
Pediatric bipolar disease: current and future perspectives for study of its long-term course and treatment. Bipolar Disord (2006) 0.83
A prospective study examining the effects of gender and sexual/physical abuse on mood outcomes in patients with co-occurring bipolar I and substance use disorders. Bipolar Disord (2009) 0.83
Disability in patients with bipolar and recurrent depressive disorder in remission: a comparative study. Indian J Psychol Med (2011) 0.81
Early intervention in bipolar disorder, part I: clinical and imaging findings. Early Interv Psychiatry (2008) 0.80
Elders with first psychiatric hospitalization for depression. Int J Geriatr Psychiatry (2009) 0.78
Investigating trajectories of social recovery in individuals with first-episode psychosis: a latent class growth analysis. Br J Psychiatry (2015) 0.77
Symptom severity, self-reported adherence, and electronic pill monitoring in poorly adherent patients with bipolar disorder. Bipolar Disord (2015) 0.77
Shared genetic factors influence risk for bipolar disorder and alcohol use disorders. Eur Psychiatry (2013) 0.76
Social functioning and age across affective and nonaffective psychoses. J Nerv Ment Dis (2015) 0.76
The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions. Ann Gen Psychiatry (2010) 0.76
Early intervention in bipolar disorder, part II: therapeutics. Early Interv Psychiatry (2008) 0.76
Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder. Psychiatry Investig (2015) 0.76
Emotion in bipolar I disorder: Implications for functional and symptom outcomes. J Abnorm Psychol (2015) 0.75
Ecologically valid support for the link between cognitive and psychosocial functioning in bipolar disorder. Psychiatry Res (2010) 0.75
Outcome of single manic episode in bipolar I disorder: a six-month follow-up after hospitalization. J Res Med Sci (2011) 0.75
An Open Trial of a Smartphone-assisted, Adjunctive Intervention to Improve Treatment Adherence in Bipolar Disorder. J Psychiatr Pract (2016) 0.75
The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines. Int J Neuropsychopharmacol (2016) 0.75
Treatment-adherence in bipolar disorder: A patient-centred approach. World J Psychiatry (2016) 0.75
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry (2000) 5.21
Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry (1993) 4.57
Psychiatric features of individuals with problematic internet use. J Affect Disord (2000) 3.19
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand (2007) 2.89
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry (2000) 2.88
Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry (1992) 2.70
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord (2001) 2.43
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry (2001) 2.38
Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry (2000) 2.34
Compulsive buying: a report of 20 cases. J Clin Psychiatry (1994) 2.29
Time course of antipsychotic effects of neuroleptic drugs. Am J Psychiatry (1989) 2.07
Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry (1999) 1.96
Risk factors for neuroleptic malignant syndrome. A case-control study. Arch Gen Psychiatry (1989) 1.94
Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry (1999) 1.93
The genetical theory of kin selection. J Evol Biol (2011) 1.93
12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry (1998) 1.91
Pharmacological treatment of kleptomania and bulimia nervosa. J Clin Psychopharmacol (1989) 1.91
Characteristics of 34 adults with psychogenic excoriation. J Clin Psychiatry (1998) 1.86
Spite and the scale of competition. J Evol Biol (2004) 1.81
Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs (2001) 1.74
CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry (2001) 1.71
MRI analysis of the cerebellum in bipolar disorder: a pilot study. Neuropsychopharmacology (1999) 1.71
Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol Psychiatry (1996) 1.62
Demography, altruism, and the benefits of budding. J Evol Biol (2006) 1.61
Rapid remission of OCD with tramadol hydrochloride. Am J Psychiatry (1999) 1.61
Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med (1992) 1.58
The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry (1999) 1.58
A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull (1994) 1.58
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry (2006) 1.58
Fewer invited talks by women in evolutionary biology symposia. J Evol Biol (2013) 1.58
Minimizing and managing antidepressant side effects. J Clin Psychiatry (1995) 1.57
Residual catatonic state following neuroleptic malignant syndrome. J Clin Psychopharmacol (2000) 1.55
Obsessive compulsive spectrum disorder. J Clin Psychiatry (1994) 1.54
Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet (1994) 1.52
Routes to indirect fitness in cooperatively breeding vertebrates: kin discrimination and limited dispersal. J Evol Biol (2009) 1.50
Changes in neuronal activation with increasing attention demand in healthy volunteers: an fMRI study. Synapse (2001) 1.49
Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry (1986) 1.47
Mania, psychosis, and antipsychotics. J Clin Psychiatry (1996) 1.47
Prevalence and severity of akathisia in patients on clozapine. Biol Psychiatry (1991) 1.47
Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics (2000) 1.45
An overview of the treatment of schizoaffective disorder. J Clin Psychiatry (1999) 1.44
Valproate in the treatment of rapid-cycling bipolar disorder. J Clin Psychopharmacol (1988) 1.44
The evolution of host use and unusual reproductive strategies in Achrysocharoides parasitoid wasps. J Evol Biol (2005) 1.44
Are impulse-control disorders related to bipolar disorder? Compr Psychiatry (1996) 1.42
fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder. J Psychiatr Res (2001) 1.42
Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry (1998) 1.40
Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry (1999) 1.40
A pilot study of rapid lithium administration in the treatment of acute mania. Bipolar Disord (2001) 1.39
Phenotypic plasticity of a cooperative behaviour in bacteria. J Evol Biol (2008) 1.33
A comparison study of body dysmorphic disorder and obsessive-compulsive disorder. J Clin Psychiatry (1998) 1.31
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry (2000) 1.28
Consistency of treatment allocation in thyrotoxicosis. Q J Med (1973) 1.27
Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders. Psychol Med (2012) 1.26
Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol Med (2000) 1.24
Colonisation of babies and their families by group B streptococci. Br Med J (Clin Res Ed) (1981) 1.23
Somatic treatment of catatonia. Int J Psychiatry Med (1995) 1.22
Neuroimaging in bipolar disorder. Bipolar Disord (2000) 1.21
Fitness correlates with the extent of cheating in a bacterium. J Evol Biol (2010) 1.21
Even more extreme fertility insurance and the sex ratios of protozoan blood parasites. J Theor Biol (2003) 1.20
Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry (1991) 1.18
Placebo effect in randomized, controlled studies of acute bipolar mania and depression. Biol Psychiatry (2000) 1.18
Personality disorders and traits in patients with body dysmorphic disorder. Compr Psychiatry (2000) 1.18
Twelve-month outcome in bipolar patients with and without personality disorders. J Clin Psychiatry (2000) 1.17
An open clinical trial of fluvoxamine treatment of psychogenic excoriation. J Clin Psychopharmacol (1999) 1.15
Understanding patterns of genetic diversity in the oak gallwasp Biorhiza pallida: demographic history or a Wolbachia selective sweep? Heredity (Edinb) (2001) 1.15
Persistent attentional dysfunction in remitted bipolar disorder. Bipolar Disord (2001) 1.15
Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset. Bipolar Disord (2001) 1.14
The incidence and diversity of Wolbachia in gallwasps (Hymenoptera; Cynipidae) on oak. Mol Ecol (2002) 1.13
Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case-control study. Biol Psychiatry (1998) 1.12
Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull (1997) 1.11
Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalization. J Clin Psychiatry (1998) 1.11
The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. J Affect Disord (2001) 1.11